Frontiers in Oncology (Oct 2023)

Radiotherapy for Non-Hodgkin’s lymphoma with cardiac infiltration: A case report

  • Weifeng Wang,
  • Zhuo Zhang,
  • Xiaocong Deng,
  • Anqi Gu,
  • Xianzhao Chen,
  • Yizheng Cai,
  • Yuting Zhao

DOI
https://doi.org/10.3389/fonc.2023.1234831
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundNon-Hodgkin’s lymphoma (NHL) with cardiac infiltration has a poor prognosis. The median OS of patients failing to respond to chemotherapy has been reported to be 1 month vs. 18 months in patients responding to chemotherapy.Case presentationHerein, we reported a case of a 57-year-old male confirmed with diffuse large B-cell lymphoma who received radiation therapy of 150-cGy daily, administered in 30 fractions to the volume of cardiac infiltration, resulting in complete relief. Chemotherapy had no curative effect. The patient was subsequently enrolled in a clinical trial and received oral administration of zanubrutinib 80mg twice daily, after which he achieved complete remission. The progression-free survival was from diagnosis (January 7, 2020) to the follow-up (September 20, 2022), amounting to 32 months.ConclusionProper irradiation dose and timing of treatment can relieve NHL symptoms.

Keywords